Abstract:Rationale: The initial hypertrophy response to cardiac pressure overload is considered compensatory, but with sustained stress, it eventually leads to heart failure. Recently, a role for recruited macrophages (mψs) in determining the transition from compensated to decompensated hypertrophy has been established. However, whether cardiac-resident immune cells influence the early phase of hypertrophy development has not been established. Objective: To assess the role of cardiac immune cells in the early hypertrophy response to cardiac pressure overload-induced by transverse aortic constriction (TAC). Methods and Results: We performed cytometry-by-time-of-flight to determine the identity and abundance of immune cells in the heart at 1 and 4 weeks after TAC. We observed a substantial increase in cardiac mψs 1 week after TAC. We then conducted Cite-Seq single-cell RNA sequencing of cardiac immune cells isolated from 4 sham and 6 TAC hearts. We identified 12 clusters of monocytes and mψs, categorized as either resident or recruited mψs, that showed remarkable changes in their abundance between sham and TAC conditions. To determine the role of cardiac-resident mψs early in the response to a hypertrophic stimulus, we used a blocking antibody against macrophage colony-stimulating factor 1 receptor (CD115). As blocking CD115 initially depletes all macrophages, we allowed the replenishment of recruited mψs by monocytes before performing TAC. This preferential depletion of resident mψs resulted in enhanced fibrosis and a blunted angiogenesis response to TAC. Mψ-depletion in CCR2 knockout mice showed that aggravated fibrosis was primarily caused by the recruitment of monocyte-derived mψs. Finally, 6 weeks after TAC these early events lead to depressed cardiac function and enhanced fibrosis, despite complete restoration of cardiac immune cells. Conclusions: Cardiac resident mψs are a heterogeneous population of immune cells with key roles in stimulating angiogenesis and inhibiting fibrosis in response to cardiac pressure overload.

Different Roles of Resident and Non-resident Macrophages in Cardiac Fibrosis

Emerging Roles of Macrophages in Heart Failure and Associated Treatment Approaches

The Roles of Macrophages in Heart Regeneration and Repair after Injury

Distinct roles of resident and nonresident macrophages in nonischemic cardiomyopathy.

Role of Cardiac Macrophages on Cardiac Inflammation, Fibrosis and Tissue Repair

Emerging Role of Macrophage-Fibroblast Interactions in Cardiac Homeostasis and Remodeling

Cardiac Resident Macrophages Prevent Fibrosis and Stimulate Angiogenesis

Distinct Origins and Functions of Cardiac Orthotopic Macrophages

Targeting Interactions between Fibroblasts and Macrophages to Treat Cardiac Fibrosis

Cardiac resident macrophages: key regulatory mediators in the aftermath of myocardial infarction

Fibroblast transdifferentiation promotes conversion of M1 macrophages and replenishment of cardiac resident macrophages following cardiac injury in mice

Insight into the Pro-inflammatory and Profibrotic Role of Macrophage in Heart Failure with Preserved Ejection Fraction.

The role of cardiac resident macrophage in cardiac aging

Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets

The Evolving Roles of Cardiac Macrophages in Homeostasis, Regeneration, and Repair

Resident and recruited macrophages differentially contribute to cardiac healing after myocardial ischemia

Cardiac macrophages in maintaining heart homeostasis and regulating ventricular remodeling of heart diseases

Cardiac resident macrophages: The core of cardiac immune homeostasis

Macrophages suppress cardiac reprogramming of fibroblasts in vivo via IFN-mediated intercellular self-stimulating circuit

Macrophage-derived CCL24 promotes fibrosis and worsens cardiac dysfunction during heart failure